Arteris Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Arteris Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 9.20 $ to 48.60 $ · Last price: 22.40 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Semiconductors
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Arteris Inc AIP | 1.1 | – | -7.7 | 87.6 | -38.0 | 22.3 | 142.4 |
| NVIDIA Corporation NVDA | 5,540.3 | 30.4 | 22.4 | 74.7 | 65.6 | 65.5 | 29.1 |
| Broadcom Inc AVGO | 1,652.3 | 55.2 | 33.7 | 75.5 | 49.0 | 23.9 | 1.1 |
| Micron Technology Inc MU | 1,269.8 | 20.7 | 15.8 | 72.6 | 80.4 | 48.9 | 512.0 |
| Advanced Micro Devices Inc AMD | 943.2 | 177.7 | 77.8 | 55.7 | 14.4 | 34.3 | 242.5 |
| Intel Corporation INTC | 546.8 | – | 145.4 | 38.9 | 6.9 | -0.5 | 337.0 |
| Arm Holdings plc ARM | 282.9 | 267.6 | 221.2 | 97.5 | 7.6 | 22.8 | 58.6 |
| Texas Instruments Incorporated TXN | 234.9 | 39.7 | 26.1 | 58.3 | 37.8 | 13.1 | 46.9 |
| Marvell Technology Group Ltd MRVL | 232.5 | 79.7 | 45.0 | 52.2 | 14.5 | 42.1 | 239.9 |
| Median of companies shown | 546.8 | 55.2 | 33.7 | 72.6 | 14.5 | 23.9 | 142.4 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | 32 | 7 | 6 | 0.26 | 12 | -4 | 27 |
| 2020 | 32 | -4 | -3 | -0.10 | 2 | -6 | 43 |
| 2021 | 38 | -22 | -23 | -1.06 | -1 | 53 | 120 |
| 2022 | 50 | -29 | -27 | -0.84 | -7 | 38 | 116 |
| 2023 | 54 | -35 | -37 | -1.03 | -16 | 15 | 103 |
| 2024 | 58 | -32 | -34 | -0.86 | -1 | -1 | 106 |
| 2025 | 71 | -33 | -35 | -0.82 | 7 | -15 | 115 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.20 | – | 16 | 23.90 | -53.00 | -3 | -3 |
| 2025: Q1 | -0.20 | – | 17 | 27.70 | -49.10 | 3 | 3 |
| 2025: Q2 | -0.22 | – | 17 | 13.20 | -55.30 | -3 | -3 |
| 2025: Q3 | -0.21 | – | 17 | 18.30 | -51.60 | 3 | 3 |
| 2025: Q4 | -0.19 | – | 20 | 30.00 | -42.20 | 3 | 3 |
| 2026: Q1 | -0.17 | – | 23 | 38.70 | -34.70 | -7 | -7 |
| 2026: Q2 | -0.30 | -36.40 | 24 | 46.10 | -58.50 | 9 | 9 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 25 of our scanner strategies — each hit links to the scanner.
Growth
Quality & Balance Sheet
Breakout & Setup
Momentum & Trend
- 21-EMA Trend
- Above the 50- & 200-SMA
- CANSLIM Type RS
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Near 52-Week High
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 2
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.18 | -0.24 – -0.13 | 97 | 47.0% | 6 |
| 12/31/2027 | 0.12 | -0.03 – 0.20 | 117 | 170.5% | 6 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 36.4% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $6.8M |
|---|---|
| Market cap | $1.06B |
| Free cash flow in year ten | $150.6M |
| Terminal value as a share of market value | 75.0% |
For comparison: over the past five years free cash flow grew by 28.8% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Arteris lizenziert Network-on-Chip-Verbindungstechnik (NoC) ausdrücklich auch für KI-Chips: Der Geschäftsbericht (10-K) nennt KI/Machine Learning als Endmarkt des Lizenz- und Royalty-Umsatzes, beschreibt KI als Beschleuniger des NoC-Geschäfts, das Produkt FlexGen arbeitet mit KI-gestützter Automatisierung — und die Filings warnen, dass Exportkontrollen auf KI-Chipdesigner in China den eigenen Umsatz senken können.
View the full file — quotes, sources, reviewed filings
„Artificial Intelligence (AI) and Generative AI are transforming the semiconductor industry, revolutionizing how our customers approach design, development, and the resulting products. The rapid expansion of AI applications across various industries, combined with the increasing complexity of electronic system design, is accelerating the use of network-on-chip technologies."
Künstliche Intelligenz (KI) und generative KI transformieren die Halbleiterindustrie und revolutionieren, wie unsere Kunden Design, Entwicklung und die daraus entstehenden Produkte angehen. Die rasche Ausbreitung von KI-Anwendungen über verschiedenste Branchen hinweg beschleunigt — zusammen mit der wachsenden Komplexität des Elektronik-Designs — den Einsatz von Network-on-Chip-Technologien.
10-K · 2026-02-12 · View SEC filing
„Demand for our interconnect IP solutions and associated royalty revenue is highly dependent on market conditions in the end markets in which our customers operate. These end markets, which include the automotive, enterprise computing, communications, artificial intelligence and machine learning, consumer electronics, and industrial markets, are subject to a number of factors including end-product acceptance and sales, competitive pressures, supply chain issues and general market conditions."
Die Nachfrage nach unseren Interconnect-IP-Lösungen und der zugehörige Royalty-Umsatz hängen stark von den Marktbedingungen in den Endmärkten unserer Kunden ab. Zu diesen Endmärkten zählen Automobil, Enterprise Computing, Kommunikation, künstliche Intelligenz und Machine Learning, Unterhaltungselektronik und Industrie; sie unterliegen einer Reihe von Faktoren, darunter Akzeptanz und Absatz der Endprodukte, Wettbewerbsdruck, Lieferkettenprobleme und allgemeine Marktbedingungen.
10-K · 2026-02-12 · View SEC filing
„Supported by AI-driven automation, FlexGen reduces manual iteration providing expert-level NoC topologies, while reducing wire-length and power which are critical to advance node designs and becoming increasingly valued."
Gestützt auf KI-getriebene Automatisierung reduziert FlexGen manuelle Iterationen und liefert Network-on-Chip-Topologien auf Expertenniveau — bei geringerer Leitungslänge und geringerem Stromverbrauch, was für Designs auf modernsten Fertigungsprozessen entscheidend ist und zunehmend geschätzt wird.
10-K · 2026-02-12 · View SEC filing
„U.S. export regulations […] may limit or adversely impact our ability to license or support our products to entities in or doing business with certain advanced AI or “supercomputer” design companies, foundries and manufacturers of assemblies and components in China. As a result of these restrictions, our customers may experience changes to or delays in their design projects, and we may face challenges to maintain our revenue and/or our revenue may decrease."
US-Exportvorschriften […] können unsere Möglichkeiten einschränken oder beeinträchtigen, unsere Produkte an Unternehmen zu lizenzieren oder zu supporten, die zu bestimmten Entwicklern fortgeschrittener KI- oder „Supercomputer“-Chips, Auftragsfertigern sowie Herstellern von Baugruppen und Komponenten in China gehören oder mit ihnen Geschäfte machen. Infolge dieser Beschränkungen kann es bei unseren Kunden zu Änderungen oder Verzögerungen ihrer Design-Projekte kommen, und es kann uns schwerfallen, unseren Umsatz zu halten — beziehungsweise unser Umsatz kann sinken.
10-Q · 2026-05-12 · View SEC filing
Filings Reviewed: 10-Q 2026-05-12 · 10-Q 2025-11-04 · 10-Q 2025-08-05 · 10-Q 2025-05-13 · 10-K 2026-02-12 · 10-K 2025-02-18
Rated on July 10, 2026 · How the Rating Is Built
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 11.9%
- More than 10% revenue growth is expected for the coming year 20.3%
- Share count grows by less than 3% a year 9.1%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 29.8%
- Gross margin at 40% or higher and without meaningful erosion 90.2%
- Goodwill from acquisitions does not grow faster than revenue 3.6%
- Net debt below twice EBITDA 46 m net cash
- Operating cash flow covers the profits of the last three years 96 m
- Return on capital at 15% or higher, or up versus two years ago -79.2%
- Insiders hold at least 10% or are net buyers 25.5%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
5/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 14.4%
- Exp. sales growth 3Y > 5% 28.8%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% 28.8%
- Net debt < 4x EBIT –
- EBIT positive, 10Y straight 1
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% –
- ROCE > 15% -79.2%
- Expected return > 10% 29.5%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Moll Laurent R | Chief Operating Officer | Sell | 100 | 21.75 | 2,175 |
| Sep 14, 2026 | Moll Laurent R | Chief Operating Officer | Sell | 9,119 | 20.84 | 190,048 |
| Sep 8, 2026 | Sinha Saurabh | Chief Financial Officer | Other | 142,835 | 0.00 | – |
| Sep 1, 2026 | Bayview Legacy, LLC | 10% Owner | Sell | 100,000 | 20.75 | 2,074,970 |
| Sep 1, 2026 | Alpern Paul L | VP and General Counsel | Sell | 4,000 | 20.77 | 83,063 |
| Sep 1, 2026 | Alpern Paul L | VP and General Counsel | Other | 4,000 | 0.56 | 2,240 |
| Sep 1, 2026 | Janac K Charles | President and CEO | Sell | 100,000 | 20.75 | 2,074,970 |
| Sep 1, 2026 | Cantwell Wayne C | Director | Other | 5,000 | 0.00 | – |
| Aug 28, 2026 | Cantwell Wayne C | Director | Other | 5,000 | 0.60 | 3,000 |
| Aug 13, 2026 | Hawkins Nicholas B. | VP and Chief Financial Officer | Sell | 10,431 | 28.26 | 294,828 |
The company
About the Company
Arteris, Inc. bietet zusammen mit seinen Tochtergesellschaften Halbleiter-System-IP-Lösungen (geistiges Eigentum) in den USA, im übrigen Amerika, in China, Korea, im übrigen asiatisch-pazifischen Raum, in Europa und im Nahen Osten an.
- Employees
- 364
- Headquarters
- Campbell, CA
- Address
- 900 E. Hamilton Avenue, 95008 Campbell, United States
- Phone
- 408 470 7300
- Website
- arteris.com
- IPO Date
- 10/27/2021
- ISIN
- US04302A1043
Management
| Name | Title | Birth Year |
|---|---|---|
| Karel Charles Janac | Chairman, CEO & President | 1959 |
| Nicholas Bryan Hawkins FCA | Executive VP & CFO | 1962 |
| Laurent R. Moll | Executive VP of Engineering & COO | 1972 |
| Paul L. Alpern | Executive VP, Chief Legal Officer & Corporate Secretary | 1965 |
| Michal Siwinski | EVP, Chief Product & Marketing Officer and GM Security Solutions | – |
| Ken Way | Executive VP of Sales & Chief Customer Officer | – |
| Jolene Bishop | Executive VP & Chief Human Resources Officer | – |
| Evin Arici Kebebew | Corporate Controller | 1985 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 08/06/2026 Arteris, Inc. (AIP): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
- 08/06/2026 Arteris, Inc. (AIP): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.